Skip to main content

Table 4 Ability to perform activities of daily living, quality of life and level of physical activity of patients with Takayasu arteritis and the control group

From: Increased modifiable cardiovascular risk factors in patients with Takayasu arteritis: a multicenter cross-sectional study

 

TAK (n=20)

CTR (n=16)

P value

HAQ (0.00–3.00)

0.56 (0.12–0.87)

0.00 (0.00–0.00)

< 0.001

SF-36 (0–100)

 Functional Capacity

62.5 (46.2–88.7)

100.0 (95.0–100.0)

< 0.001

 Physical function

50.0 (0.0–100.0)

100.0 (100.0–100.0)

0.008

 Pain

41.0 (34.2–63.5)

84.0 (69.2–100.0)

< 0.001

 General health

61.0 (43.2–80.7)

92.0 (79.5–97.7)

< 0.001

 Vitality

55.0 (35.0–72.5)

77.5 (55.0–85.0)

0.066

 Social aspects

88.0 (66.0–100.0)

100.0 (84.7–100.0)

0.194

 Emotional aspects

100.0 (33.0–100.0)

100.0 (67.0–100.0)

0.195

 Mental health

60.0 (53.0–84.0)

82.0 (75.0–97.0)

0.034

WIQ (0–100)

 Walking distance

68.0 (37.3–100.0)

100.0 (100.0–100.0)

< 0.001

 Walking speed

64.1 (38.6–79.9)

100.0 (97.3–100.0)

< 0.001

 Ability to climb stairs

58.3 (42.7–85.4)

100.0 (96.7–100.0)

< 0.001

 Overall score

64.4 (42.4–86.9)

100.0 (88.9–100.0)

< 0.001

IPAQ-SF (%)

 Low

14 (60.0)

3 (18.7)

0.013

 Moderate

6 (30.0)

9 (56.2)

0.080

 High

0

2 (12.5)

–

 METs per week

453.0 (240.0–751.7)

1693 (1089.0–2206.0)

< 0.001

  1. Data are presented as median (25–75%) or percentage (%)
  2. CTR Control group, HAQ Health Assessment Questionnaire, IPAQ-SF International Physical Activity Questionnaire Short Version, METs Metabolic equivalent, SF-36 Short Form Health Survey, TAK Takayasu arteritis, WIQ Walking Impairment Questionnaire